FORGOTTEN HISTORY: Do wall street analysts like pfizer stock - The Untold Story

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $134.9 billion, the company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas.

Shares of this pharmaceutical giant have underperformed the broader market over the past year. PFE has declined 4.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 10.6%. In 2025, PFE stock is down 8%, compared to SPX’s 5.3% fall on a YTD basis.